Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
ASSETS
Investments in real estate, net	$ 700,618	$ 704,762
Investments in unconsolidated entities	33,709	33,505
Cash and cash equivalents	21,307	19,290
Restricted cash	24,335	24,938
Loans receivable, net (Note 5)	56,229	57,005
Accounts receivable, net	6,030	5,347
Deferred rent receivable and charges, net	27,793	28,222
Other intangible assets, net	3,852	3,948
Other assets	13,630	14,183
TOTAL ASSETS	887,503	891,200
LIABILITIES:
Debt, net	472,813	471,561
Accounts payable and accrued expenses	25,639	26,426
Due to related parties	3,333	3,463
Other liabilities	13,639	12,981
Total liabilities	515,424	514,431
COMMITMENTS AND CONTINGENCIES (Note 15)
EQUITY:
Common stock, $0.001 par value; 900,000,000 shares authorized; 22,786,741 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	23	23
Additional paid-in capital	851,234	852,476
Distributions in excess of earnings	(936,151)	(921,925)
Total stockholders’ equity	369,888	374,403
Non-controlling interests	2,191	2,366
Total equity	372,079	376,769
TOTAL LIABILITIES, REDEEMABLE PREFERRED STOCK, AND EQUITY	887,503	891,200
Series A Preferred Stock
EQUITY:
Preferred stock	$ 176,007	$ 185,704
Preferred stock, shares authorized (in shares)	34,211,995	34,611,501
Series A1 Preferred Stock
EQUITY:
Preferred stock	$ 277,585	$ 256,935
Preferred stock, shares authorized (in shares)	27,880,928	27,904,974
Series D Preferred Stock
EQUITY:
Preferred stock	$ 1,190	$ 1,190
Preferred stock, shares authorized (in shares)	26,991,590	26,991,590